ADCYAP1 and glioblastoma: Precisely, PACAP and its receptor co-localized in areas of human GBM expressing vimentin and MMP-2, two markers of mesenchymal phenotype, as well as in cells expressing ZO-1, a marker of epithelial phenotype.